Symbicort 100/3 is a prescription medication used in the management and treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a combination inhaler that contains two active ingredients: budesonide, a corticosteroid that reduces inflammation in the airways, and formoterol, a long-acting beta2-adrenergic agonist (LABA) that helps to relax the muscles around the airways and makes breathing easier. The "100/3" refers to the dose of budesonide (100 micrograms) and formoterol (3 micrograms) per inhalation. Symbicort is designed for regular use to control and prevent symptoms such as wheezing and shortness of breath. It is not intended for the immediate relief of acute bronchospasm or asthma attacks. When using Symbicort 100/3, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medication. This inhaler, used for asthma and COPD, combines two medicines that may cause side effects. Common side effects include headache, throat irritation, and possible yeast infections in the mouth. Rare but serious side effects can include increased blood pressure, changes in vision, and signs of infection. Because Symbicort can cause dizziness or tremors, it's important to understand how it affects you before engaging in activities such as driving. Always inform your doctor about any other medications you're taking to avoid adverse interactions. Following these precautions ensures the effectiveness of the treatment while minimizing risks.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.